50 related articles for article (PubMed ID: 16000583)
1. Combination therapy of insulin-like growth factor binding protein-3 and retinoid X receptor ligands synergize on prostate cancer cell apoptosis in vitro and in vivo.
Liu B; Lee KW; Li H; Ma L; Lin GL; Chandraratna RA; Cohen P
Clin Cancer Res; 2005 Jul; 11(13):4851-6. PubMed ID: 16000583
[TBL] [Abstract][Full Text] [Related]
2. The effects of glycemic index on prostate cancer progression in a xenograft mouse model.
Galván GC; Macias E; Sanders S; Ramirez-Torres A; Stock S; You S; Riera CE; Tamukong P; Smith-Warner SA; Genkinger JM; Luthringer DJ; Freeman MR; Freedland SJ
Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):348-354. PubMed ID: 38082056
[TBL] [Abstract][Full Text] [Related]
3. Emerging Immunotherapy Approaches for Treating Prostate Cancer.
Meng L; Yang Y; Mortazavi A; Zhang J
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762648
[TBL] [Abstract][Full Text] [Related]
4. The potential of retinoids for combination therapy of lung cancer: Updates and future directions.
Tripathi SK; Pandey K; Panda M; Spinella MJ; Rengasamy KR; Biswal BK
Pharmacol Res; 2019 Sep; 147():104331. PubMed ID: 31254665
[TBL] [Abstract][Full Text] [Related]
5. The Role of Nuclear Receptors in Prostate Cancer.
Shiota M; Fujimoto N; Kashiwagi E; Eto M
Cells; 2019 Jun; 8(6):. PubMed ID: 31212954
[TBL] [Abstract][Full Text] [Related]
6. Exosomes secreted by placental stem cells selectively inhibit growth of aggressive prostate cancer cells.
Peak TC; Praharaj PP; Panigrahi GK; Doyle M; Su Y; Schlaepfer IR; Singh R; Vander Griend DJ; Alickson J; Hemal A; Atala A; Deep G
Biochem Biophys Res Commun; 2018 May; 499(4):1004-1010. PubMed ID: 29627574
[TBL] [Abstract][Full Text] [Related]
7. Role of insulin-like growth factor-binding proteins in the pathophysiology and tumorigenesis of gastroesophageal cancers.
Kashyap MK
Tumour Biol; 2015 Nov; 36(11):8247-57. PubMed ID: 26369544
[TBL] [Abstract][Full Text] [Related]
8. IGFBP3, a transcriptional target of homeobox D10, is correlated with the prognosis of gastric cancer.
Xue M; Fang Y; Sun G; Zhuo W; Zhong J; Qian C; Wang L; Wang L; Si J; Chen S
PLoS One; 2013; 8(12):e81423. PubMed ID: 24386080
[TBL] [Abstract][Full Text] [Related]
9. Regulation of retinal endothelial cell apoptosis through activation of the IGFBP-3 receptor.
Zhang Q; Soderland C; Steinle JJ
Apoptosis; 2013 Mar; 18(3):361-8. PubMed ID: 23291901
[TBL] [Abstract][Full Text] [Related]
10. Single-injection HPLC method for rapid analysis of a combination drug delivery system.
Tucker RM; Parcher BW; Jones EF; Desai TA
AAPS PharmSciTech; 2012 Jun; 13(2):605-10. PubMed ID: 22535518
[TBL] [Abstract][Full Text] [Related]
11. The retinoid X receptors and their ligands.
Dawson MI; Xia Z
Biochim Biophys Acta; 2012 Jan; 1821(1):21-56. PubMed ID: 22020178
[TBL] [Abstract][Full Text] [Related]
12. IGFBP-3 is a metastasis suppression gene in prostate cancer.
Mehta HH; Gao Q; Galet C; Paharkova V; Wan J; Said J; Sohn JJ; Lawson G; Cohen P; Cobb LJ; Lee KW
Cancer Res; 2011 Aug; 71(15):5154-63. PubMed ID: 21697285
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of native human insulin-like growth factor binding protein-6.
Taferner A; Micutkova L; Hermann M; Jansen-Dürr P; Pircher H
J Cell Commun Signal; 2011 Dec; 5(4):277-89. PubMed ID: 21484185
[TBL] [Abstract][Full Text] [Related]
14. Novel protective properties of IGFBP-3 result in enhanced pericyte ensheathment, reduced microglial activation, increased microglial apoptosis, and neuronal protection after ischemic retinal injury.
Kielczewski JL; Hu P; Shaw LC; Li Calzi S; Mames RN; Gardiner TA; McFarland E; Chan-Ling T; Grant MB
Am J Pathol; 2011 Apr; 178(4):1517-28. PubMed ID: 21435441
[TBL] [Abstract][Full Text] [Related]
15. Retinoid pathway and cancer therapeutics.
Bushue N; Wan YJ
Adv Drug Deliv Rev; 2010 Oct; 62(13):1285-98. PubMed ID: 20654663
[TBL] [Abstract][Full Text] [Related]
16. Interaction of insulin-like growth factor-binding protein-3 and BAX in mitochondria promotes male germ cell apoptosis.
Jia Y; Lee KW; Swerdloff R; Hwang D; Cobb LJ; Sinha Hikim A; Lue YH; Cohen P; Wang C
J Biol Chem; 2010 Jan; 285(3):1726-32. PubMed ID: 19887447
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation.
Kielczewski JL; Jarajapu YP; McFarland EL; Cai J; Afzal A; Li Calzi S; Chang KH; Lydic T; Shaw LC; Busik J; Hughes J; Cardounel AJ; Wilson K; Lyons TJ; Boulton ME; Mames RN; Chan-Ling T; Grant MB
Circ Res; 2009 Oct; 105(9):897-905. PubMed ID: 19762684
[TBL] [Abstract][Full Text] [Related]
18. Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patients.
Yu JZ; Warycha MA; Christos PJ; Darvishian F; Yee H; Kaminio H; Berman RS; Shapiro RL; Buckley MT; Liebes LF; Pavlick AC; Polsky D; Brooks PC; Osman I
J Transl Med; 2008 Nov; 6():70. PubMed ID: 19025658
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis in human prostate cancer cells by insulin-like growth factor binding protein-3 does not require binding to retinoid X receptor-alpha.
Zappala G; Elbi C; Edwards J; Gorenstein J; Rechler MM; Bhattacharyya N
Endocrinology; 2008 Apr; 149(4):1802-12. PubMed ID: 18162523
[TBL] [Abstract][Full Text] [Related]
20. IGFBP-3 sensitizes prostate cancer cells to interferon-gamma-induced apoptosis.
Fang P; Hwa V; Little BM; Rosenfeld RG
Growth Horm IGF Res; 2008 Feb; 18(1):38-46. PubMed ID: 17719815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
